These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27085392)

  • 1. Levothyroxine treatment restored the decreased circulating fibroblast growth factor 21 levels in patients with hypothyroidism.
    Wang G; Liu J; Yang N; Hu Y; Zhang H; Miao L; Yao Z; Xu Y
    Eur J Intern Med; 2016 Jun; 31():94-8. PubMed ID: 27085392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alteration of serum soluble CD40 ligand levels in overt and subclinical hypothyroidism.
    Akinci B; Comlekci A; Yener S; Demir T; Bayraktar F; Yuksel F; Yesil S
    Hormones (Athens); 2007; 6(4):327-33. PubMed ID: 18055424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of blood inflammatory marker levels in patients with hypothyroidism under levothyroxine treatment.
    Marchiori RC; Pereira LA; Naujorks AA; Rovaris DL; Meinerz DF; Duarte MM; Rocha JB
    BMC Endocr Disord; 2015 Jun; 15():32. PubMed ID: 26100072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
    Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
    J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment.
    Tzotzas T; Krassas GE; Konstantinidis T; Bougoulia M
    Thyroid; 2000 Sep; 10(9):803-8. PubMed ID: 11041458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of L-thyroxine replacement therapy on ischemia-modified albümin and malondialdehyde levels in patients with overt and subclinical hypothyroidism.
    Erem C; Suleyman AK; Civan N; Mentese A; Nuhoglu İ; Uzun A; Coskun H; Deger O
    Endocr Res; 2016 Nov; 41(4):350-360. PubMed ID: 27111422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyroidism.
    Duntas LH; Mantzou E; Koutras DA
    Thyroid; 2002 Nov; 12(11):1003-7. PubMed ID: 12490078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased atherogenic low-density lipoprotein cholesterol in untreated subclinical hypothyroidism.
    Mikhail GS; Alshammari SM; Alenezi MY; Mansour M; Khalil NA
    Endocr Pract; 2008; 14(5):570-5. PubMed ID: 18753099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy.
    Arem R; Patsch W
    Arch Intern Med; 1990 Oct; 150(10):2097-100. PubMed ID: 2222095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Worthy Finding: Decrease in Total Cholesterol and Low-Density Lipoprotein Cholesterol in Treated Mild Subclinical Hypothyroidism.
    Zhao M; Liu L; Wang F; Yuan Z; Zhang X; Xu C; Song Y; Guan Q; Gao L; Shan Z; Zhang H; Zhao J
    Thyroid; 2016 Aug; 26(8):1019-29. PubMed ID: 27270263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein alterations, hepatic lipase activity, and insulin sensitivity in subclinical hypothyroidism: response to L-T(4) treatment.
    Brenta G; Berg G; Arias P; Zago V; Schnitman M; Muzzio ML; Sinay I; Schreier L
    Thyroid; 2007 May; 17(5):453-60. PubMed ID: 17542675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect.
    Milionis HJ; Tambaki AP; Kanioglou CN; Elisaf MS; Tselepis AD; Tsatsoulis A
    Thyroid; 2005 May; 15(5):455-60. PubMed ID: 15929667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study.
    Caraccio N; Ferrannini E; Monzani F
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1533-8. PubMed ID: 11932277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherogenic Lipoproteins in Subclinical Hypothyroidism and Their Relationship with Hepatic Lipase Activity: Response to Replacement Treatment with Levothyroxine.
    Brenta G; Berg G; Miksztowicz V; Lopez G; Lucero D; Faingold C; Murakami M; Machima T; Nakajima K; Schreier L
    Thyroid; 2016 Mar; 26(3):365-72. PubMed ID: 26839156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels in overt and subclinical hypothyroid patients were reduced by levothyroxine replacement.
    Akinci B; Comlekci A; Ali Ozcan M; Demir T; Yener S; Demirkan F; Yuksel F; Yesil S
    Endocr J; 2007 Feb; 54(1):45-52. PubMed ID: 17090955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea.
    Jung CH; Sung KC; Shin HS; Rhee EJ; Lee WY; Kim BS; Kang JH; Kim H; Kim SW; Lee MH; Park JR; Kim SW
    Korean J Intern Med; 2003 Sep; 18(3):146-53. PubMed ID: 14619383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Short-Term Hypothyroidism on the Lipid Transfer to High-Density Lipoprotein and Other Parameters Related to Lipoprotein Metabolism in Patients Submitted to Thyroidectomy for Thyroid Cancer.
    Sigal GA; Tavoni TM; Silva BMO; Kalil Filho R; Brandão LG; Maranhão RC
    Thyroid; 2019 Jan; 29(1):53-58. PubMed ID: 30412041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proprotein convertase subtilisin/kexin type 9 (PCSK9), soluble lectin-like oxidized LDL receptor 1 (sLOX-1) and ankle brachial index in patients with differentiated thyroid cancer.
    Ozkan C; Akturk M; Altinova AE; Cerit ET; Gulbahar O; Yalcin MM; Cakir N; Balos Toruner F
    Endocr J; 2015; 62(12):1091-9. PubMed ID: 26490048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma FGF21 levels are increased in patients with hypothyroidism independently of lipid profile.
    Lee Y; Park YJ; Ahn HY; Lim JA; Park KU; Choi SH; Park DJ; Oh BC; Jang HC; Yi KH
    Endocr J; 2013; 60(8):977-83. PubMed ID: 23759753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid profile and lipoprotein (a) as a risk factor for cardiovascular disease in women with subclinical hypothyroidism.
    Canturk Z; Cetinarslan B; Tarkun I; Canturk NZ; Ozden M
    Endocr Res; 2003 Aug; 29(3):307-16. PubMed ID: 14535632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.